Table 2 Asthma and spirometry in chronic rhinosinusitis subsets (mean, 95% CI; or percentage).
From: Pathophysiological classification of chronic rhinosinusitis
| Â | Nasal Polyps with Aspirin Sensitivity (NPasa) | Nasal Polyps with Other Features (NPother) | CRS without Nasal Polyps (CRSsNP) | Osteomeatal Complex Disease (OMC) |
|---|---|---|---|---|
Clinical Asthma | 15/17 (88%) Triad Asthma | 23/32 (72%) | 19/28 (68%) | 14/20 (70%) |
Spirometry | N = 12 | N = 22 | N = 14 | N = 14 |
FEV1/FVC (%) A | 64.4% (59.8 to 69.0) | 70.9% (65.3 to 76.5) | 78.0% (72.3 to 83.6) § | 79.8% (73.6 to 86.0) §§ |
FEV1/FVC<70% A | 9/12 (83%) | 9/22 (41%) [<0.05] | 3/14 (21%) [0.008] | 2/14 (14%) [0.003] |
FEF25%–75% (%) | 48.4% (35.9 to 60.8) | 59.7% (47.9 to 71.5) | 73.9% (58.0 to 89.7) | 69.5% (55.8 to 83.2) |
FEF25%–75%<70% B | 10/11 (91%) | 11/20 (55%) [0.04] | 4/14 (29%) [0.002] | 6/14 (43%) [0.02] |